Sobi France

Sobi France is a leading biopharmaceutical company dedicated to developing and delivering innovative therapies for patients with rare diseases. With a strong commitment to improving patient outcomes, Sobi focuses on areas such as haematology, immunology, and genetic disorders.

Founded on the principles of scientific excellence and patient-centricity, Sobi France aims to transform the lives of individuals affected by complex health conditions. The company invests heavily in research and development, collaborating with healthcare professionals and institutions to advance treatment options.

At Sobi, we believe in the power of collaboration and innovation. Our team of experts works tirelessly to bring new therapies to market, ensuring that patients have access to the best possible care. We are committed to ethical practices and transparency in all our operations.

Core Activities:

• Research and Development of Biopharmaceuticals
• Clinical Trials and Regulatory Affairs
• Patient Support Programs
• Collaboration with Healthcare Providers

Our vision is to be a global leader in the biopharmaceutical industry, recognized for our contributions to rare disease treatment. We strive to create a sustainable future by prioritizing environmental responsibility and community engagement.

With a dedicated workforce and a passion for making a difference, Sobi France is poised to continue its growth and impact in the healthcare sector. We invite you to join us on this journey towards better health for all.